Figure 3 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer

<p>Survival outcomes and multivariable analysis of prognostic factors in the ICI–TKI group. <b>A,</b> Kaplan–Meier curves for OS and PFS. The results of a survival analysis conducted on the ICI–TKI group with and without irAEs. The red line represents the patient group without irAE...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autor principal:	Bunpei Isoda (22273897) (author)
Otros Autores:	Masanobu Shiga (22273900) (author), Shuya Kandori (20806494) (author), Shota Takahashi (22273903) (author), Akifumi Omiya (22273906) (author), Tomoki Ishida (22273909) (author), Kotoe Matsuda (22273912) (author), Hiromichi Sakurai (22273915) (author), Bryan J. Mathis (20803922) (author), Ken Tanaka (22273918) (author), Manabu Komine (22273921) (author), Masahiro Iinuma (22273924) (author), Akira Joraku (22273927) (author), Hiromitsu Negoro (17411086) (author), Masakazu Tsutsumi (22273930) (author), Takamitsu Inoue (22273933) (author), Jun Miyazaki (22273936) (author), Hiroyuki Nishiyama (18287202) (author)
Publicado:	2025
Materias:	Cancer Tumor Biology Molecular and Cellular Biology Immuno-oncology Clinical Research and Trials Antibody Immunotherapy Cell Signaling Clinical-stage Research Genitourinary Cancers Renal cancer Immunotherapy Toxicities/irAEs Immune Cells And The Microenvironment Protein Tyrosine Kinases Tumor Microenvironment
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Figure 3 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer

Ejemplares similares